Sign up to save your podcasts
Or
Share STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the diabetes community and the need for fair and equitable allocation of incretin-based therapies in the face of ongoing drug shortages and overwhelming demand.
View all episodes
By Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
4.7
1313 ratings
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the diabetes community and the need for fair and equitable allocation of incretin-based therapies in the face of ongoing drug shortages and overwhelming demand.
More shows like Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
View all
JAMA Clinical Reviews
498 Listeners
Diabetes Core Update
104 Listeners
Juicebox Podcast: Type 1 Diabetes
1,629 Listeners
10% Happier with Dan Harris
12,711 Listeners
The Curbsiders Internal Medicine Podcast
3,357 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
730 Listeners
The Peter Attia Drive
8,579 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
The Holistic GLP-1 Podcast with Elizabeth McGann
48 Listeners
The Hunter Williams Podcast
106 Listeners
Huberman Lab
29,248 Listeners
The Metabolic Classroom with Dr. Ben Bikman
230 Listeners
The Dr. Tyna Show
1,639 Listeners
Docs Who Lift
388 Listeners
The Dr. Gabrielle Lyon Show
1,200 Listeners